Mass spectrometry-based metabolomics may uncover novel pathogenic mechanisms of metabolic diseases
and cancers. Innovative cutting-edge technology will permit to perform metabolomics on tissue samples.
Such an approach adds a topological dimension, which has the potential to revolutionize conventional histo-
pathological assessment. Complementary to the clinical metabolomics facility of the Center of Laboratory
Medicine of the University Hospital of Bern, a technology-driven metabolomics platform is to be located in the
Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel). There, in collaboration with Wa-
ters, metabolomics on tissue samples will be developed for clinical applications.
We are looking for

1 doctoral student (3 years)

Requirements

• A Master in science or biomedical sciences or equivalent


• Interest in metabolomics and in mass spec technologies


• Good communication skills


• Good English language skills

We offer

• Salary according to the Swiss National Foundation scale


• Embedding in metabolomics team

Contact
Start: as soon as possible
More information:
www.ukc.insel.ch/de/dienstleistungen/clinical-metabolomics-facility/ and well established research
groups on metabolic liver disease
www.swissliver.ch/de/Forschung/Forschungsgruppe_Dufour
and cancer
Institute of Pathology: Research Group Perren Marioni Schmitt Dettmer
Application:
Please send your application by email to Prof. Jean-François Dufour, jean-francois.dufour@dbmr.unibe.ch
(letter of application, CV and references in a single pdf file)

..
University of Bern, DBMR Hepatology, Murtenstrasse 35, 3008 Bern, www.unibe.ch

Apply now